Global healthcare company Viatris achieved a milestone by producing its first batch of locally manufactured ARVs at its upgraded Isando facility, reported Daily Maveric(17 Dec 2024).
“This investment aims to address the country’s heavy reliance on imported medicines and strengthen its healthcare infrastructure.”